Harvest Investment Services LLC Acquires Shares of 23,048 Harrow, Inc. (NASDAQ:HROW)

Harvest Investment Services LLC acquired a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 23,048 shares of the company's stock, valued at approximately $773,000. Harvest Investment Services LLC owned approximately 0.06% of Harrow at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Tower Research Capital LLC TRC grew its stake in shares of Harrow by 769.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 1,652 shares of the company's stock valued at $55,000 after acquiring an additional 1,462 shares in the last quarter. MetLife Investment Management LLC increased its holdings in Harrow by 5.7% during the 4th quarter. MetLife Investment Management LLC now owns 18,908 shares of the company's stock worth $634,000 after purchasing an additional 1,026 shares during the last quarter. Canada Pension Plan Investment Board raised its position in shares of Harrow by 10,500.0% in the 4th quarter. Canada Pension Plan Investment Board now owns 42,400 shares of the company's stock valued at $1,423,000 after purchasing an additional 42,000 shares in the last quarter. Barclays PLC boosted its stake in shares of Harrow by 15.1% during the 4th quarter. Barclays PLC now owns 60,550 shares of the company's stock valued at $2,032,000 after buying an additional 7,957 shares during the last quarter. Finally, Neuberger Berman Group LLC raised its holdings in Harrow by 128.0% in the fourth quarter. Neuberger Berman Group LLC now owns 200,529 shares of the company's stock valued at $6,728,000 after acquiring an additional 112,588 shares in the last quarter. Hedge funds and other institutional investors own 72.76% of the company's stock.

Harrow Stock Down 3.0 %

Shares of Harrow stock traded down $0.77 during midday trading on Monday, hitting $24.79. The company's stock had a trading volume of 194,778 shares, compared to its average volume of 502,708. Harrow, Inc. has a 1-year low of $10.04 and a 1-year high of $59.23. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 3.23. The firm has a market capitalization of $883.68 million, a P/E ratio of -26.37 and a beta of 0.46. The stock has a 50-day simple moving average of $25.47 and a 200-day simple moving average of $34.61.

Harrow (NASDAQ:HROW - Get Free Report) last released its earnings results on Thursday, March 27th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.14. Harrow had a negative net margin of 19.75% and a negative return on equity of 45.57%. The company had revenue of $66.83 million during the quarter, compared to the consensus estimate of $66.01 million. As a group, sell-side analysts expect that Harrow, Inc. will post -0.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on HROW. HC Wainwright reaffirmed a "buy" rating and issued a $57.00 target price on shares of Harrow in a research report on Monday, March 31st. B. Riley dropped their price objective on shares of Harrow from $69.00 to $65.00 and set a "buy" rating on the stock in a report on Tuesday, April 1st.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.